Background: A diagnosis and treatment of chest wall tuberculosis (CWTB) is both difficult and controversial. The aim of this study was to collect information on the optimal treatment for CWTB. Methods: The clinical features, radiographic findings, and treatment outcomes of 26 patients, who underwent surgery and were diagnosed histopathologically, were retrospectively analyzed. Results: The most common presenting symptom was a palpable mass found in 24 patients (92.3%). In all patients, CT revealed a soft tissue mass that was accompanied by a central low density, with or without peripheral rim enhancement. The sensitivity and specificity of the bone scintigram for bone involvement were 87.5% and 100%, respectively. CWTB was diagnosed preoperatively by aspiration cytology and smear for acid-fast bacilli in five out of 11 patients. Twenty-three patients (88.5%) underwent a radical excision and three underwent incision/drainage or an incisional biopsy. The duration of antituberculous medication was 7.5±3.98 months with a follow-up period of 28.2±26.74 months. Among the 20 patients who completed their treatment, nine received chemotherapy for six months or less and 11 received chemotherapy for nine months or more. Two patients had a recurrence four and seven months after starting their medication. Conclusion: A 6 month regimen may be appropriate for CWTB patients who have undergone a complete excision.
Introduction
Despite the dramatic decline in the incidence of tuberculosis during the past several decades, it still remains a significant public health problem in the world, largely due to widespread incidence of HIV infections 1, 2 . Chest wall tuberculosis (CWTB) makes up 1 to 5% of all cases of musculoskeletal tuberculosis [3] [4] [5] , which in turn represents 1 to 2% of tuberculosis cases overall [6] [7] [8] . Although the chest wall is an uncommon site for osteoarticular tuberculosis 9 , tuberculosis is the most common type of inflammatory lesion in the ribs after a metastatic neoplasm that causes destructive rib lesions 10 . However, a diagnosis of CWTB can be difficult, because the clinical presentation may resemble a pyogenic abscess or chest wall tumor 11, 12 . In addition, CWTB often fails to respond to antituberculous chemotherapy, and there is some controversy regarding the appropriate therapeutic strategy 11, 12 . This study analyzed retrospectively 26 CWTB patients who underwent surgery to evaluate the clinical features and radiographic findings, and assessed the efficacy of the therapeutic strategy. The main focus was to collect Numbers in parentheses are percentage. information on the optimal treatment and suggest the appropriate duration of antituberculous medication for CWTB patients.
Materials and Methods
The study population consisted of 26 CWTB patients who underwent surgery at Kyungpook National University Hospital (Daegu, Korea) between March 1998 and June 2005. The diagnosis was made based on the histopathological evidence of caseating granuloma with Langhans' giant cells in surgically procured specimens, regardless of the presence or absence of tubercle bacilli in the smear and/or the acid-fast bacilli culture from the needle aspirates or debrided materials. A HIV test was not performed on any patient.
From the medical records, all the clinical data, including clinical characteristics, bone scintigraphic findings, microbiology and cytopathology data, and treatment was analyzed. The CT images were examined by a thoracic radiologist (K.N.J.) and a pulmonologist (S.I.C.). The examination included determination of the number and location of the lesions, the chest wall layer involved, the associated pleural and parenchymal lesions, and the presence or absence of bone destruction. The surgical biopsy specimens and surgical records were reviewed by a pulmonary pathologist (T.I.P.) and a thoracic surgeon (E.B.L.), respectively.
Statistical analysis
The data is expressed as a mean±SD for continuous variables, and percentages for categorical variables. The categorical data were compared using a chi-squared test (Fisher's exact test). Two-sided p-values ＜0.05 were considered significant.
Results

Clinical characteristics
There were 11 men and 15 women, with a mean age of 34.3 years ( Table 1 ). All the patients were immunocompetent and there was no evidence of any intravenous drug abuse. The most common presenting symptom was a palpable chest wall mass found in 24 patients (92.3%). The remaining two complained of chest pain. The mean duration of symptoms was 72.5 days. Twenty-three patients (88.5%) had no smoking history, while three were current smokers.
CT and bone scintigraphy findings
In all patients, CT revealed a soft tissue mass accompanied by a central low density, with or without peripheral rim enhancement ( Figure 1A, B) . Concomitantly, one patient also had another lesion that involved only the subcutaneous layer ( Figure 1C ). Of the 27 lesions, 17 (63.0%) were located in the rib shaft, seven (26.0%) in the costochondral junction, two (7.4%) in the sternum/parasternal area, and one (3.7%) in the costovertebral joint (Table 2) . With regard to the chest wall layers involved, both the inner and outer sides of the ribs were affected in 22 lesions (81.5%), only the outer side of the rib in four lesions (14.8%), and only the subcutaneous layer in one lesion (3.7%) ( Figure 1 ). Six patients (23.1%) had an accompanying loculated pleural effusion with or without calcification, while suspicious pulmonary tuberculous lesions were found in 14 patients (53.8%) regardless of their activity. The CT scan revealed, only two patients (7.7%) to have obvious bone destruction, while bone involvement was actually identi- fied in a total of 17 patients (65.4%), including 15 (57.7%) surgically and seven (26.9%) pathologically. Of the 10 patients undergoing a bone scintigram, hot uptake was observed in seven, which was subsequently confirmed either surgically or pathologically (positive predictive value, 100%) ( Table 3 ). In contrast, of the three patients who did not show hot uptake, two did not have bone involvement (negative predictive value, 66.7%). The sensitivity and specificity of the bone scintigram for bone involvement were 87.5% and 100%, respectively.
Microbiology and cytopathology results
The microbiology and cytopathology results for the needle aspirates obtained from the subjects were examined, even though they were included in this study based on the pathological diagnosis on the surgical specimens. The acid-fast bacilli smear or Mycobacterium tuberculosis culture for the needle aspirates were positive in four out of nine patients (44.4%). Two out of nine (22.2%) were smear-positive and two out of seven (28.6%) were culture-positive (Table 4) . Of the seven patients who underwent aspiration cytology, three (42.9%) were found to have caseating granulomas with giant cells. Based on the fine needle aspiration, tuberculosis was diagnosed in six of the 11 patients (54.5%). Since it takes approximately one to two months to obtain the results of cultures for Mycobacterium tuberculosis, a preoperative diagnosis was made in five patients, using the smear for acid-fast bacilli and cytology. For surgically procured specimens, all 10 patients had a negative smear for acid-fast bacilli, while three out of nine had a positive culture for Mycobacterium tuberculosis. The stain for acid-fast bacilli on the paraffin blocks of the tissue specimens was positive in two patients (7.7%). Overall, nine patients were diagnosed micro- Microbiologic diagnoses were made in 9 patients. Numbers in parentheses are percentages. biologically either from the results of the acid-fast bacilli smear and stain on a paraffin block, or from the Mycobacterium tuberculosis culture.
Surgery combined with antituberculous medication and treatment outcomes
Twenty-three patients (88.5%) underwent a radical excision with or without decortication. Incision/drainage or curettage was performed in two patients. Of these two patients, one had diffuse pleural thickening with calcification, and the other was diagnosed with tuberculosis at the site of a wound infection after coronary artery bypass graft surgery. The remaining patient received only an incisional biopsy, as the sternum and parasternal area were extensively involved by tuberculosis.
Twelve patients (46.2%) had a prior history of antituberculous chemotherapy. In these patients, the symptoms of CWTB occurred before (n=4), within one year (n=4), and later than two years (n=4) after the end of the previous medication. The duration of therapy was 7.5±3.98 months and the follow-up period was 28.2±26.74 months. Six patients were classified as being "undecided cases": two were lost to follow-up; two were still undergoing antituberculous chemotherapy; one had died due to gastrointestinal bleeding; and one dropped out due to the adverse effect of medication. Of the remaining 20 patients, nine (45.0%) received medication for six months or less, and 11 (55.0%) received medication for nine months or more. Figure 2 shows the duration of antituberculous medication in each patient. Two patients experienced a recurrence of CWTB, which occurred while undergoing chemotherapy after surgery: four and seven months after the start of chemotherapy, respectively. The two patients received antituberculous medication for a total of 12 months. Except for these two patients, no more recurrences were noted in either groups (≤6 months versus ≥9 months, p＞0.05).
Discussion
Three mechanisms have been suggested to explain the pathogenesis of CWTB: direct extension from underlying pleural or pulmonary parenchymal disease; hematogenous dissemination associated with the activation of a dormant tuberculous focus; and direct extension from a lymphadenitis in the chest wall 1 . In this study, six patients (23.1%) had a loculated pleural effusion. Of these five had chest wall lesions located adjacent to the pleural effusion, suggesting the possibility of a direct extension from the pleural disease in the form of empyema necessitates. However, this may be considered to be a less common cause of CWTB compared with the latter two 13 . Skeletal tuberculosis is believed to result from either the lymphatic or hematogenous dissemination of bacilli from the site of the primary infection in the lungs 2, 13 . Faure et al 1 suggested that an infection of the lymph nodes in the chest results from pleuritis caused by an invasion of the tubercle bacilli. The lymph nodes of the chest wall then become caseous. This necrotic and caseous material then burrows externally to form a cold abscess in the chest wall. In this study, most of the chest wall abscesses spanned the inner to the outer sides of the ribs, with the exception of four lesions located on the outer side only. In addition, most patients presented with a solitary mass rather than with multiple lesions. Hence, these findings support the pathogenesis of lymphatic spread. Clinicians usually perform a needle aspiration or biopsy of a lesion, first to establish a diagnosis of tuberculosis and second to exclude other diagnoses. This procedure can show caseating granulomas with giant cells, acid-fast bacilli in a direct smear, or Mycobacterium tuberculosis in a culture. In clinical practice, the diagnostic yield of a needle aspiration is low: 29% reported by Faure et al These results showed that a preoperative smear for acidfast bacilli and/or cytology from aspirated pus provided diagnostic information in five out of 11 patients. However, Hsu et al 12 reported that a needle aspiration should be performed when a diagnosis of tuberculosis is suspected before making any therapeutic decision. The standard treatment for CWTB is controversial. From an analysis of 32 cases of superficial tuberculous abscess, Ward 14 suggested that the prompt use of antituberculous drugs is the most important factor in achieving a successful outcome. Others 12, 15, 16 have reported good results using only antituberculous drugs for several months. However, the total number of cases was small, and the follow-up was frequently short. In a report by Faure et al 1 of the eight patients that underwent medical treatment, only one was cured by a four-drug regimen. Similarly, Hsu et al reported the successful outcome of surgical debridement in six patients, while combination chemotherapy alone was only successful in one case 12 . In this study, only one patient received chemotherapy alone for 12 months and improved remarkably. Therefore, medical treatment should be tried first before using a surgical approach, even though only a few patients with CWTB respond to antituberculous medication.
According to the previous reports 11, 12, 17 , a 9-to 12-month regimen of chemotherapy is recommended, including isoniazid, rifampicin, ethambutol, and pyrazinamide. However, these recommendations were based on retrospective data, and there are no reports of a randomized controlled trial of antituberculous medication for CWTB. Tuberculosis can now be treated with a 6-month regimen, which was previously reported to be effective for extrapulmonary tuberculosis 18 . This suggests that the same regimen may also be appropriate for CWTB patients who have undergone a complete excision. In this study, two patients experienced a recurrence of CWTB during chemotherapy: four and seven months after the start of chemotherapy, These patients had received antituberculous medication for a total of 12 months. Although these two patients were classified into the group ≥9 months according to the duration of chemotherapy, these patients could have been divided into separate groups (≤6 months and ≥9 months). In addition, it is unclear if this was a true recurrence or a paradoxical reaction. A tuberculous cold abscess can develop while being treated for pulmonary tuberculosis, even though such an abscess can disappear after continued treatment with the same regimen. Therefore, the development of a tuberculous cold abscess does not necessarily indicate treatment failure 15 . Interestingly, Mycobacterium tuberculosis was not cultured in the aspirate from the recurred abscesses in these two patients, suggesting the possibility of a paradoxical reaction. After excluding these two cases, no recurrence was found in either groups: ≤6 months and ≥9 months. These results suggest that a 6 month regimen may also be applicable to CWTB patients who have undergone a complete excision.
The methods of surgical treatment are also controversial. Brown ommended adequate surgical debridement and an antituberculous regimen to prevent recurrence. Therefore, a radical or wide excision would appear to be the surgical method of choice, despite the lack of adequate data. This study had several limitations. First, this study was retrospective and only included those patients who had undergone surgery. Therefore, selection bias should be considered. Second, the mean follow-up period of 28 months was not long enough. For nonimmunosuppressed subjects, the ideal minimal follow-up period should be five years 20 . Third, many of the patients were not diagnosed microbiologically, but were histopathologically proven. Hence, there is the possibility of granulomatous inflammation due to a nontuberculous mycobacterial infection and other causes.
From previous reports 1, 12 and our these results, the following recommendations can be made for diagnostic and therapeutic approaches for CWTB ( Figure 3) . First, when a diagnosis of CWTB is suspected, a needle aspiration should be performed to obtain specimens for a smear/culture and cytopathological diagnosis. Second, antituberculous medication should be started if tuberculosis is diagnosed or is strongly suspected. However, if the diagnosis is unclear, a surgical approach is the next step for a diagnosis and treatment. Moreover, a surgical resection should be considered if the lesion fails to improve or worsens after 1∼3 months of medication. Third, a 6-month regimen may be appropriate for patients who have successfully undergone a wide excision. In non-operated patients, 9-to 12-month duration medication is commonly used even though the appropriate duration of chemotherapy remains unclear.
In conclusion, a fine-needle aspiration should be performed in suspected CWTB patients suspected of having CWTB. A 6-month regimen may be appropriate for CWTB patients whose lesions have been excised com-pletely.
